Study record

MOTS-c preserves mitochondrial subpopulation bioenergetics and genome integrity to attenuate cardiac ischemia reperfusion injury

Santhanam SS, Jayaraman S, Rajesh SS et al. · Mol Biol Rep · 2026

Ex vivoMOTS-c administeredEvidence tier D

What this study reported

Reported that ischemia-reperfusion impaired mechanical recovery, increased oxidative stress and lowered mitochondrial enzyme activities, membrane potential, mtDNA copy number and mitochondrial gene expression in isolated rat hearts. Reported that MOTS-c added before ischemia or at reperfusion was associated with better post-ischemic mechanical recovery and partial preservation of these mitochondrial measures, with responses varying across parameters.

Limitations

Very small group sizes; isolated female rat hearts without systemic circulation or blood components; supraphysiological peptide exposure in the perfusate and no mechanistic validation.

Study record

Annotated fields for this study
Study modelTissue / sample study (ex vivo)
Substance studiedMOTS-c administeredSynthetic MOTS-c was given to cells, animals or people.
Speciesrat
System studiedIsolated female Wistar rat hearts on a Langendorff perfusion system with global ischemia and reperfusion
PopulationNot reported
DesignControlled ex vivo perfused heart experiment
Sample size as reported6 hearts per group
Control groupischemia-reperfusion hearts without MOTS-c
Route (data field only)other
Endpoints measuredcardiac mechanical recovery; myocardial injury markers; mitochondrial bioenergetics in subsarcolemmal and interfibrillar populations; oxidative stress; mtDNA copy number; mitochondrial regulatory gene expression
Pathways measuredOxidative stress · SIRT1 / PGC-1α / biogenesis
Research areasCardiovascular · Mitochondrial biology
Evidence tierD — Cell, tissue or analytical
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Mammalian
Sample size
Small
Controls
Appropriate
Outcome validity
Surrogate
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.